A Russian SME from Kaluga region, jointly with an R&D institute, developed a technology and a prototype for computer-aided laser station for contactless measurement of mechanical stresses and controlling local defects in electronic industry. The SME is looking for partners for technical cooperation and commercial agreements with technical assistance.
Ref: 11 RU 86FG 3MMZ

A Spanish university has developed a new EDG2 inhibitor compound for treatment of rheumatoid arthritis patients, specifically non-responder patients to conventional anti-inflammatory treatments. EDG2 blockage is useful to ameliorate clinical evolution of arthritis in presence of inflammatory activity. The university is looking for pharmaceutical companies interested in signing a license agreement.
Ref: 11 ES 24D8 3N1L

A French institute, specialised in nanostructured materials, thin films and polarimetric instrumentation, has developed a new process yielding continuous Graphene films at wafer scale and on thickness control. This process is dedicated to microelectronics industry with applications such as transparent electrodes for flat displays or photovoltaic cells to semiconducting thin layers. The French institute is looking for partners for licensing agreements and technological cooperation.
Ref: 11 FR 38m7 3LNA

Scientists at a Dutch academic medical centre have developed a novel methodology to boost antibody production. This can be used in many applications in vaccine development. The academic medical centre is looking for companies active in the drug delivery field e.g. manufacturers of vaccines for a license agreement.
Ref: 11 NL 60FI 3MV7

A German company that was founded in 1895 offers an in-depth expertise in papermaking, coating technology, melt extrusion coating, layer design and print/image quality and has begun to develop and test innovative paper for printed electronics. This paper could be used for printing smart objects, functional intelligent packaging or smart labels. The company is looking for cooperation partners in a technical cooperation scheme.
Ref: 11 DE 1593 3MRI

SME based in North East England is seeking partners to collaborate on a solution for insomnia. Insomnia is a major market opportunity that affects 5% of the population. The Company has identified 10 candidate molecules which have a history of prior human exposure (and are therefore de-risked) which have putative action against a well validated target from a sleep therapeutic. Each partner would be required to perform one of the tasks set out. Research could lead to a Eurostars submission.
Ref: 11 GB 47P8 3MT7

Researchers at a German university have discovered novel isolated nucleic acids comprising both a pederin and a psymberin gene cluster from previously inaccessible symbiotic producers. These offer a significant scientific potential for new potent antitumor therapeutics. Biotech and or pharmaceutical companies are sought for licensing agreements or research collaboration.
Ref: 11 DE 0855 3N05

A Dutch biotech company is specialized in improvement and development of medicinal herbal products (phytomedicines) and the discovery of natural leads for the development of new phytogenic drugs. Currently the company has developed a series of technological concepts with proof of biological principal including well characterized biological active products: extracts as well as active pharmaceutical ingredients from plants.  The company is looking for partners for co-development of new products.
Ref: 11 NL 60AH 3MZJ

A Spanish SME has developed an innovative fully-automatic pilot device for marine navigational purposes that is able to operate without human supervision and taking, if necessary, evasive manoeuvres. The system is a programmable device for anti collision control applications, capable of producing evasive manoeuvres to avoid collisions and/or minimise its effects, as well as geographical obstacles or marine mechanical structures. License partnership agreements are sought.
Ref: 11 ES 73DI 3MNX

A Russian R & D institute from Kaluga region developed a technology for modification of polylactide for producing biodegradable materials with a controlled destruction rate to be applied in medical implants and in packaging. The authors seek partners for technical cooperation.
Ref: 11 RU 86FG 3MO1

An Hungarian non-profit SME is looking for manufacturer who is capable of manufacturing medical instruments with an image recording device. The company is seeking manufacturers, who can produce 10-500 pieces of low-cost (200-220EUR/pieces) dermatology devices for mass production within one or two months.
Ref: 11 HU 50S5 3KA4

An Andalusian Technology Centre with expertise in food industry is looking for companies and research groups that provide active packaging technologies for food. This organization is interested in signing agreements for technical cooperation with other agents, experts in this technology in order to make new developments in active packaging applied to fruits and vegetables.
Ref: 11 ES 27F4 3MMW

A German university has found out that two proteins may serve as novel markers for the diagnosis and prognosis of breast cancer. They may be used for the determination of a patient`s prognosis and for a therapy efficacy within the scope of personalised medicine. Cost-effective breast cancer tests are possible, convenient for patients due to easy access and applicable to young and old patients. A patent license and/or research collaboration is offered to innovative pharma / biotech companies.
Ref: 11 DE 0855 3N09

A German SME offers expertise and products for control and protection devices for high voltage substations. The technology is easy to be used and prevents damages to energy systems, e.g. due to voltage fluctuations and reactive power. The company seeks partners for licensing or commercial agreements with technical assistance. The partners should be energy suppliers, network operators or industrial customers operating their own energy supply systems.
Ref: 11 DE 0855 3M1X

A large German Research Institute has developed a process for efficient gasification of wet biomass. In general wet biomass cannot be used effectively but the new technology provides a possibility of converting contaminated biomass by a hydrothermal process. Moreover it helps to save waste management costs and generates revenue from selling the gas. It is particularly interesting for biotechnology and chemical industry. The institute seeks a license agreement or a technical cooperation.
Ref: 11 DE 1380 3MMG

A French company offers its expertise in cardiovascular health and disease. Activities are focused on demonstration of activity (optimisation, health claims) and safety (REACH Regulation) profile of drugs extracts and new treatment of pharmaceutical, food complement, food and ingredient provider origin. Partners requesting technical consultancy or support on testing the influence of free radicals, antioxidant power of synthetic or natural compounds are sought.
Ref: 11 FR 32I9 3LIH